Ketamine Infusion for Adolescent Depression

What is the purpose of this trial?

The purpose of this study is to determine if Ketamine infusion will result in improvement of depressive symptoms in adolescents that have failed at least one trial with a pharmacological agent.


Participation Guidelines

Ages: 13 - 18 years

Gender: Both


Thrasher Research Fund

Start Date: 09/24/2015

End Date: 10/31/2017

Last Updated: 06/22/2018

Study HIC#: 1506016041

Get Involved

For more information about this study, contact:
Angie Landeros-Weisenberger
+1 203-737-4809
angeli.landeros@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image